FDA

114 stories · following the connections

Business

SANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot Ulcers

By Nasdaq OMXMar 24, 2016, 1:00 PM UTC

Business

U.S. Food and Drug Administration (FDA) Grants Breakthrough Therapy Designation to Immunomedics for Sacituzumab Govitecan for the Treatment of Patients With Triple-Negative Breast Cancer

By Nasdaq OMXFeb 5, 2016, 2:28 PM UTC